Abingdon, United Kingdom

Mark Richard Ashton

USPTO Granted Patents = 9 

Average Co-Inventor Count = 9.7

ph-index = 6

Forward Citations = 61(Granted Patents)


Company Filing History:


Years Active: 2008-2012

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Mark Richard Ashton: Innovator in CRTH2-Mediated Treatments

Introduction

Mark Richard Ashton is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of medical treatments, particularly in addressing CRTH2-mediated diseases. With a total of nine patents to his name, Ashton's work has the potential to impact the treatment of various inflammatory conditions.

Latest Patents

Ashton's latest patents focus on the treatment of CRTH2-mediated diseases and conditions. His inventions provide indole derivatives that antagonize prostaglandin D, which can be utilized to treat inflammatory diseases mediated by this compound. This innovative approach highlights his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Ashton has worked with several prominent companies, including Oxagen Limited and Asterand UK Limited. His experience in these organizations has allowed him to develop and refine his inventions, contributing to the advancement of medical treatments.

Collaborations

Ashton has collaborated with notable professionals in his field, including Edward Andrew Boyd and David Middlemiss. These partnerships have likely enriched his work and fostered innovation in the treatments he has developed.

Conclusion

Mark Richard Ashton is a distinguished inventor whose work in CRTH2-mediated treatments showcases his dedication to medical innovation. His contributions have the potential to significantly improve the lives of individuals suffering from inflammatory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…